Skip to main content

Advertisement

SpringerLink
Log in

Genetics of motor neuron disease

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

The number of genes associated with motor neuron degeneration has increased considerably over the past few years. As more gene mutations are identified, the hope arises that certain common themes and/or pathways become clear. In this overview, we focus on recent discoveries related to amyotrophic lateral sclerosis (ALS), spinal muscular atrophies (SMA), and distal hereditary motor neuropathies (dHMN). It is striking that many of the mutated genes that were linked to these diseases encode proteins that are either directly or indirectly involved in axonal transport or play a role in RNA metabolism. We hypothesize that both phenomena are not only crucial for the normal functioning of motor neurons, but that they could also be interconnected. In analogy with the situation after acute stress, axonal mRNA translation followed by retrograde transport of the signal back to the nucleus could play an important role in chronic motor neuron diseases. We hope that information on the genetic causes of these diseases and the insight into the pathologic processes involved could ultimately lead to therapeutic strategies that prevent or at least slow this degenerative process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rosen DR, Siddique T, Patterson D, et al.: Mutations in Cu/ Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59–62.

    Article  PubMed  CAS  Google Scholar 

  2. Yang Y, Hentati A, Deng HX, et al.: The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001, 29:160–165.

    Article  PubMed  CAS  Google Scholar 

  3. Hadano S, Hand CK, Osuga H, et al.: A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001, 29:166–173.

    Article  PubMed  CAS  Google Scholar 

  4. Chen YZ, Bennett CL, Huynh HM, et al.: DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004, 74:1128–1135. Identification of mutations in the SETX gene in an autosomal dominant form of juvenile ALS. This study also reports the presence of a DNA/RNA helicase domain in the senataxin protein and a possible function in RNA processing.

    Article  PubMed  CAS  Google Scholar 

  5. Nishimura AL, Mitne-Neto M, Silva HC, et al.: A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 2004, 75:822–831. First report of a missense mutation in the VAPB gene in ALS8. This paper also suggests that a dysfunction of membrane vesicle transport along microtubules could cause selective motor neuron death.

    Article  PubMed  CAS  Google Scholar 

  6. Greenway MJ, Andersen PM, Russ C, et al.: ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet 2006, 38:411–413. This study identified mutations in the ANG gene that were associated with ALS in Irish and Scottish populations. In total, seven missense mutations were found in 15 individuals, of whom four had familial ALS and 11 apparently had "sporadic" ALS.

    Article  PubMed  CAS  Google Scholar 

  7. Gurney ME, Pu H, Chiu AY, et al.: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264:1772–1775.

    Article  PubMed  CAS  Google Scholar 

  8. Reaume AG, Elliott JL, Hoffman EK, et al.: Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996, 13:43–47.

    Article  PubMed  CAS  Google Scholar 

  9. Broom WJ, Ay I, Pasinelli P, et al.: Inhibition of SOD1 expression by mitomycin C is a non-specific consequence of cellular toxicity. Neurosci Lett 2006, 393:184–188. Apparent inhibition of SOD1 expression by mitomycin C is a nonspecific consequence of mitomycin C-induced cellular toxicity.

    Article  PubMed  CAS  Google Scholar 

  10. Saito Y, Yokota T, Mitani T, et al.: Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model. J Biol Chem 2005, 280:42826–42830. Transgenic mice were constructed containing a modified siRNA in their genome that silences SOD1. Crossbreeding these mice with the mutant SODG93A mice prevented the development of the disease.

    Article  PubMed  CAS  Google Scholar 

  11. Miller TM, Kaspar BK, Kops GJ, et al.: Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann Neurol 2005, 57:773–776. Using adeno-associated virus carrying an siRNA against SOD1, it was shown that SOD1 expression in spinal motor neurons could be diminished and that this resulted in a preservation of grip strength.

    Article  PubMed  CAS  Google Scholar 

  12. Ralph GS, Radcliffe PA, Day DM, et al.: Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 2005, 11:429–433. Lentiviral expression of RNAi targeting the human SOD1 gene resulted in a considerable delay of the symptoms and dramatically extended survival of the mutant SOD1G93A mice.

    Article  PubMed  CAS  Google Scholar 

  13. Raoul C, Abbas-Terki T, Bensadoun JC, et al.: Lentiviralmediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005, 11:423–428. Lentiviral expression of siRNA against SOD1 silenced its expression and influenced onset and progression of the disease in the mutant SOD1G93A mice.

    Article  PubMed  CAS  Google Scholar 

  14. Williamson TL, Cleveland DW: Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 1999, 2:50–56.

    Article  PubMed  CAS  Google Scholar 

  15. Rao MV and Nixon RA: Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review. Neurochem Res 2003, 28:1041–1047.

    Article  PubMed  CAS  Google Scholar 

  16. Jablonka S, Wiese S, and Sendtner M: Axonal defects in mouse models of motoneuron disease. J Neurobiol 2004, 58:272–286.

    Article  PubMed  CAS  Google Scholar 

  17. Kieran D, Hafezparast M, Bohnert S, et al.: A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 2005, 169:561–567. Crossbreeding Loa mice that have a mutant dynein motor protein with mutant SOD1G93A transgenic mice resulted in a delayed disease progression and an increased survival of the Loa SOD1G93A mice. This study also found that the presence of mutant dynein in SOD1G93A motor neurons restores the axonal transport deficits, at least in vitro.

    Article  PubMed  CAS  Google Scholar 

  18. Teuchert M, Fischer D, Schwalenstoecker B, et al.: A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp Neurol 2006, 198:271–274. Confirmation of the Loa SOD1G93A results by crossbreeding Cra1 mice, which have another dynein mutation, with the SOD1G93A mice.

    Article  PubMed  CAS  Google Scholar 

  19. Gros-Louis F, Gaspar C, Rouleau GA: Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim Biophys Acta 2006, In press. A review that contains a systematic overview of all mutated genes, as well as of all reported genetic as well as environmental risk factors that could contribute to familial and sporadic ALS.

  20. Panzeri C, De Palma C, Martinuzzi A, et al.: The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain 2006, In press.

  21. Millecamps S, Gentil BJ, Gros-Louis F, et al.: Alsin is partially associated with centrosome in human cells. Biochim Biophys Acta 2005, 1745:84–100. Full-length and truncated forms of alsin were overexpressed in different cell lines, and co-localization of alsin with centrosomal markers was found.

    Article  PubMed  CAS  Google Scholar 

  22. Tudor EL, Perkinton MS, Schmidt A, et al.: ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J Biol Chem 2005, 280:34735–34740.

    Article  PubMed  CAS  Google Scholar 

  23. Cai H, Lin X, Xie C, et al.: Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci 2005, 25:7567–7574. Knockout mice for Als2 were generated and these mice did not show major motor deficits or motor neuron degeneration. Primary cultured neurons from these Als2-/-mice were more susceptible to oxidative stress.

    Article  PubMed  CAS  Google Scholar 

  24. Hadano S, Benn SC, Kakuta S, et al.: Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet 2006, 15:233–250. Knockout mice for Als2 were made and these mice did not show any developmental, reproductive or motor abnormalities. However, an age-dependent loss of Purkinje cells and disturbance of spinal motor neurons associated with astrocytosis and microglial cell activation were observed.

    Article  PubMed  CAS  Google Scholar 

  25. Rabin BA, Griffin JW, Crain BJ, et al.: Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 1999, 122:1539–1550.

    Article  PubMed  Google Scholar 

  26. De Jonghe P, Auer-Grumbach M, Irobi J, et al.: Autosomal dominant juvenile ALS and distal hereditary motor neuronopathy with pyramidal tract signs: Synonyms for the same disorder? Brain 2002, 125:1320–1325.

    Article  PubMed  Google Scholar 

  27. Moreira MC, Klur S, Watanabe M, et al.: Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet 2004, 36:225–227.

    Article  PubMed  CAS  Google Scholar 

  28. Grohmann K, Schuelke M, Diers A, et al.: Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 2001, 29:75–77.

    Article  PubMed  CAS  Google Scholar 

  29. Nishimura AL, Al-Chalabi A and Zatz M: A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum Genet 2005, 118:499–500. Haplotype analysis of eight families with the P56S mutation in the VAPB gene identified a common founder 23 generations ago.

    Article  PubMed  Google Scholar 

  30. Skehel PA, Fabian-Fine R, Kandel ER: Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc Natl Acad Sci U S A 2000, 97:1101–1106.

    Article  PubMed  CAS  Google Scholar 

  31. Pennetta G, Hiesinger PR, Fabian-Fine R, et al.: Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 2002, 35:291–306.

    Article  PubMed  CAS  Google Scholar 

  32. Greenway MJ, Alexander MD, Ennis S, et al.: A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004, 63:1936–1938.

    PubMed  CAS  Google Scholar 

  33. Leland PA, Staniszewski KE, Park C, et al.: The ribonucleolytic activity of angiogenin. Biochemistry 2002, 41:1343–1350.

    Article  PubMed  CAS  Google Scholar 

  34. Lefebvre S, Burglen L, Reboullet S, et al.: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80:155–165.

    Article  PubMed  CAS  Google Scholar 

  35. Monani UR: Spinal muscular atrophy: A deficiency in an ubiquitous protein; a motor neuron-specific disease. Neuron 2005, 48:885–896. Review that gives an up-to-date overview of the pathogenesis of SMA and of the recent advances made in the understanding of this disease.

    Article  PubMed  CAS  Google Scholar 

  36. Schrank B, Gotz R, Gunnersen JM, et al.: Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A 1997, 94:9920–9925.

    Article  PubMed  CAS  Google Scholar 

  37. Jablonka S, Bandilla M, Wiese S, et al.: Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy. Hum Mol Genet 2001, 10:497–505.

    Article  PubMed  CAS  Google Scholar 

  38. Briese M, Esmaeili B, Sattelle DB: Is spinal muscular atrophy the result of defects in motor neuron processes? Bioessays 2005, 27:946–957.

    Article  PubMed  CAS  Google Scholar 

  39. Harding AE: Inherited neuronal atrophy and degeneration predominantly of lower motor neurons. In Peripheral Neuropathy, edn 3. Edited by Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF. Philadelphia: WB Saunders; 1993:1051–1064.

    Google Scholar 

  40. Irobi J, Dierick I, Jordanova A, et al.: Unravelling the genetics of Distal Hereditary Motor Neuronopathies. NeuroMolecular Med 2006, 8:131–146.

    Article  PubMed  CAS  Google Scholar 

  41. Irobi J, Van Impe K, Seeman P, et al.: Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004, 36:597–601. First report that mutations in the HSPB8 gene encoding the HSP22 protein can cause dHMN-II. Mutant HSP22 formed intracellular aggregates, showed increased binding to HSP27, and inhibited cell division.

    Article  PubMed  CAS  Google Scholar 

  42. Evgrafov OV, Mersiyanova I, Irobi J, et al.: Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004, 36:602–606. This study identified mutations in the HSPB1 gene encoding HSP27 as the cause of dHMN-II and CMT-2. Mutant HSP27 inhibited cell division in a neuronal cell line, and co-expression with NF-L in a cell line devoid of cytoplasmic intermediate filaments caused formation of aggregates.

    Article  PubMed  CAS  Google Scholar 

  43. Antonellis A, Ellsworth RE, Sambuughin N, et al.: Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003, 72:1293–1299.

    Article  PubMed  CAS  Google Scholar 

  44. Windpassinger C, Auer-Grumbach M, Irobi J, et al.: Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004, 36:271–276. Identification of mutations in the BSCL2 gene that cause dHMN and Silver syndrome. This study also shows that seipin is an integral membrane protein of the endoplasmic reticulum.

    Article  PubMed  CAS  Google Scholar 

  45. Puls I, Jonnakuty C, LaMonte BH, et al.: Mutant dynactin in motor neuron disease. Nat Genet 2003, 33:455–456. Identification of a mutation in the DCTN1 gene in a family with a slowly progressive, autosomal dominant form of lower motor neuron disease without sensory symptoms.

    Article  PubMed  CAS  Google Scholar 

  46. Tang B, Liu X, Zhao G, et al.: Mutation analysis of the small heat shock protein 27 gene in Chinese patients with Charcot-Marie-Tooth disease. Arch Neurol 2005, 62:1201–1207.

    Article  PubMed  Google Scholar 

  47. Ackerley S, James PA, Kalli A, et al.: A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet 2006, 15:347–354. The effect of expressing one form of mutant HSP27 was analyzed in cultured cortical neurons. It was found that this leads to aggregation and sequestration in the cytoplasm of cellular components, including NF-M and p150 dynactin.

    Article  PubMed  CAS  Google Scholar 

  48. Jordanova A, Irobi J, Thomas FP, et al.: Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006, 38:197–202. Identification of mutations in the YARS gene in families with a dominant intermediate form of CMT. The specific distribution of YARS in the axonal termini of motor neurons and neuroblastoma cells is disturbed by mutations in the YARS protein.

    Article  PubMed  CAS  Google Scholar 

  49. Irobi J, Van den Bergh P, Merlini L, et al.: The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain 2004, 127:2124–2130.

    Article  PubMed  Google Scholar 

  50. Magre J, Delepine M, Khallouf E, et al.: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001, 28:365–370.

    Article  PubMed  CAS  Google Scholar 

  51. Agarwal AK, Garg A: Seipin: a mysterious protein. Trends Mol Med 2004, 10:440–444. Overview of the potential mechanism by which mutations in BSCL2 could lead to Berardinelli-Seip congenital lipodystrophy 2 and dHMN.

    Article  PubMed  CAS  Google Scholar 

  52. Miao M, Chan SL, Fletcher GL, et al.: The rat ortholog of the presumptive flounder antifreeze enhancer-binding protein is a helicase domain-containing protein. Eur J Biochem 2000, 267:7237–7246.

    Article  PubMed  CAS  Google Scholar 

  53. Cox GA, Mahaffey CL, Frankel WN: Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron 1998, 21:1327–1337.

    Article  PubMed  CAS  Google Scholar 

  54. Levy JR, Sumner CJ, Caviston JP, et al.: A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J Cell Biol 2006, 172:733–745. Analysis of the cellular effects of a point mutation (G59S) in the p150 subunit of dynactin. The mutation caused a decreased microtubule binding and an enhanced dynein and dynactin aggregation. The authors suggest that both a loss of function and a gain of function could be responsible for the motor neuron degeneration.

    Article  PubMed  CAS  Google Scholar 

  55. LaMonte BH, Wallace KE, Holloway BA, et al.: Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002, 34:715–727.

    Article  PubMed  CAS  Google Scholar 

  56. Hafezparast M, Klocke R, Ruhrberg C, et al.: Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003, 300:808–812.

    Article  PubMed  CAS  Google Scholar 

  57. Reid E, Kloos M, Ashley-Koch A, et al.: A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 2002, 71:1189–1016.58.

    Article  PubMed  CAS  Google Scholar 

  58. Mersiyanova IV, Perepelov AV, Polyakov AV, et al.: A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000, 67:37–46.

    Article  PubMed  CAS  Google Scholar 

  59. Perlson E, Hanz S, Medzihradszky KF, et al.: From snails to sciatic nerve: Retrograde injury signaling from axon to soma in lesioned neurons. J Neurobiol 2004, 58:287–294. Review of the mechanisms responsible for signaling of acute axonal damage to the cell body and nucleus of a lesioned neuron. It is proposed that injury signals form part of a complex that is assembled by a combination of different processes, including posttranslational modifications, such as phosphorylation, regulated and transient proteolysis, and local axonal protein synthesis. Subsequently, this complex is retrogradely transported from the injury site to the nucleus.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurobiology, Campus Gasthuisberg O&N2 PB1022, Herestraat 49, B-3000, Leuven, Belgium

    Ludo Van Den Bosch PhD

Authors
  1. Ludo Van Den Bosch PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent Timmerman PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ludo Van Den Bosch PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Den Bosch, L., Timmerman, V. Genetics of motor neuron disease. Curr Neurol Neurosci Rep 6, 423–431 (2006). https://doi.org/10.1007/s11910-996-0024-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-996-0024-9

Keywords

Search

Navigation